Merck Provides Update on Phase III Clinical Program for Preladenant,... 
Drug maker staff found to have joined research without identifying 
NEW YORK, May 24, 2013 (AP) — Alkermes PLC said Thursday that it was... 
Special Reports
Pharmalot
Over the past two years, two studies showed the Niaspan cholesterol drug did not benefit patients. Yet AbbVie has...
5
For the first time since opening an internal probe into clinical trials run in Japan for its Diovan blood pressure...
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us...
Our experts are on hand to offer industry-specific advice.